Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4457611000168111 | Sarclisa (isatuximab 500 mg / 25 mL) injection, 25 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4457621000168116 | Sarclisa 500 mg/25 mL injection, 25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sarclisa 500 mg/25 mL injection, 25 mL vial | Is a | Sarclisa | true | Inferred relationship | Some | ||
Sarclisa 500 mg/25 mL injection, 25 mL vial | Is a | isatuximab 500 mg/25 mL injection, vial | true | Inferred relationship | Some | ||
Sarclisa 500 mg/25 mL injection, 25 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Sarclisa 500 mg/25 mL injection, 25 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Sarclisa 500 mg/25 mL injection, 25 mL vial | has unit of use | vial | true | Inferred relationship | Some | 773947158 | |
Sarclisa 500 mg/25 mL injection, 25 mL vial | has intended active ingredient | isatuximab | true | Inferred relationship | Some | 1761020453 | |
Sarclisa 500 mg/25 mL injection, 25 mL vial | has Australian BoSS | isatuximab | true | Inferred relationship | Some | 1761020453 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sarclisa 500 mg/25 mL injection, 1 x 25 mL vial | has TPUU | True | Sarclisa 500 mg/25 mL injection, 25 mL vial | Inferred relationship | Some | 303370180 |
Sarclisa 500 mg/25 mL injection, 1 x 25 mL vial | has TPUU | True | Sarclisa 500 mg/25 mL injection, 25 mL vial | Inferred relationship | Some | 1411650942 |
Reference Sets
Black Triangle Scheme reference set
Australian dialect reference set
Trade product unit of use reference set